Frontiers in Immunology | Vaccines and Molecular Therapeutics

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all

rita carsetti

Bambino Gesù Children's Hospital (IRCCS)

Rome, Italy

Specialty Chief Editor

Vaccines and Molecular Therapeutics
denise l. doolan

Australian Institute of Tropical Health and Medicine, James Cook University

Cairns, Australia

Specialty Chief Editor

Vaccines and Molecular Therapeutics
selidji todagbe agnandji

Centre de Recherche Médicales de Lambaréné

Lambaréné, Gabon

Associate Editor

Vaccines and Molecular Therapeutics
nahid ali

Indian Institute of Chemical Biology (CSIR)

Kolkata, India

Associate Editor

Vaccines and Molecular Therapeutics

Vaccines and Molecular Therapeutics

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

rita carsetti

denise l. doolan

selidji todagbe agnandji

nahid ali

Articles

A selective C5a-derived peptidomimetic enhances IgG response following inactivated SARS-CoV-2 immunization and confers rapid disease resolution following murine coronavirus infection

Development of a multi-epitope vaccine from outer membrane proteins and identification of novel drug targets against Francisella tularensis: an In Silico approach

mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients

Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network

Research Topics

Role of Glycosylation in Vaccine Design: Modulating the Targeting of Pathogen Recognition Receptors and Shaping Adaptive Immunity

Advancements in Vaccine Strategies for Chronic Infectious Disease Management

Advancing Livestock Health: Innovative Vaccine Strategies to Combat Antimicrobial Resistance

Community Series in Immune studies of SARS-CoV2 and vaccines using preclinical modeling, Volume II